CPRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $3,781,377.73

Catalyst Pharmaceuticals Insider Trading History Chart

Catalyst Pharmaceuticals Share Price & Price History

^$15.10

▼ -0.03 (-0.20%)

As of 04/22/2024 01:00 AM ET

Days: 30 | 90 | 365

Healthcare Takes A Big Step Forward With The Help Of AI

From The Bull Report | Ad

The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.

Click here to see why this small company is trusted by the Mayo Clinic

Catalyst Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/8/2024	David S Tierney	Director	Sell	25,000	$15.68	$392,000.00	348,874
3/27/2024	Brian Elsbernd	Insider	Sell	25,000	$16.44	$411,000.00	124,433
12/12/2023	David S Tierney	Director	Sell	50,000	$13.32	$666,000.00	333,541
12/11/2023	Alicia Grande	CFO	Sell	60,000	$13.76	$825,600.00	50,557
12/8/2023	Alicia Grande	CFO	Sell	40,000	$14.28	$571,200.00	50,557
12/5/2023	Steve Miller	Insider	Sell	40,000	$14.24	$569,600.00	647,457
5/15/2023	Patrick J. McEnany	CEO	Sell	26,151	$13.23	$345,977.73	3,945,436
4/5/2023	David S Tierney	Director	Sell	30,000	$16.83	$504,900.00	313,541
3/29/2023	Carmen Jeffrey Del	Insider	Sell	40,000	$16.70	$668,000.00	7,541
3/28/2023	Alicia Grande	CFO	Sell	58,216	$16.54	$962,892.64	50,557
3/22/2023	Alicia Grande	CFO	Sell	41,784	$16.50	$689,436.00	50,557
3/20/2023	Brian Elsbernd	Insider	Sell	50,000	$16.07	$803,500.00	138,076
12/6/2022	Gary Ingenito	Insider	Sell	5,918	$16.85	$99,718.30	30,802
11/23/2022	Philip H. Coelho	Director	Sell	9,999	$17.45	$174,482.55	149,553
11/23/2022	Steve Miller	COO	Sell	20,000	$17.34	$346,800.00	553,791
11/22/2022	Alicia Grande	CFO	Sell	120,000	$16.53	$1,983,600.00	27,442
11/21/2022	Patrick J. McEnany	CEO	Sell	150,000	$15.33	$2,299,500.00	3,902,606
11/21/2022	Philip H. Coelho	Director	Sell	70,000	$15.23	$1,066,100.00	179,553
11/21/2022	Steve Miller	COO	Sell	80,000	$15.28	$1,222,400.00	573,791
11/18/2022	Patrick J. McEnany	CEO	Sell	350,000	$15.62	$5,467,000.00	3,902,606
11/15/2022	Alicia Grande	CFO	Sell	60,000	$15.77	$946,200.00	147,442
11/11/2022	Donald A Denkhaus	Director	Sell	20,000	$16.59	$331,800.00	277,666
11/11/2022	Preethi Sundaram	insider	Sell	56,786	$16.38	$930,154.68
9/23/2022	Alicia Grande	CFO	Sell	60,000	$11.90	$714,000.00	207,442
9/16/2022	Alicia Grande	CFO	Sell	90,000	$13.50	$1,215,000.00	267,442
9/15/2022	Preethi Sundaram	insider	Sell	18,214	$14.49	$263,920.86	22,053
9/14/2022	Alicia Grande	CFO	Sell	50,000	$15.57	$778,500.00	357,442
9/14/2022	Donald A Denkhaus	Director	Sell	20,000	$15.34	$306,800.00	297,666
9/13/2022	Patrick J. McEnany	CEO	Sell	80,765	$15.33	$1,238,127.45	4,849,452
9/13/2022	Steve Miller	COO	Sell	107,933	$16.90	$1,824,067.70	653,791
8/29/2022	Alicia Grande	CFO	Sell	57,000	$14.20	$809,400.00	407,442
8/26/2022	Alicia Grande	CFO	Sell	11,095	$14.40	$159,768.00	464,442
8/22/2022	David S Tierney	Director	Sell	20,000	$14.16	$283,200.00	308,207
8/18/2022	Steve Miller	COO	Sell	150,000	$13.53	$2,029,500.00	761,724
8/17/2022	Alicia Grande	CFO	Sell	130,741	$13.86	$1,812,070.26	475,537
6/22/2022	Gary Ingenito	Insider	Sell	6,152	$6.61	$40,664.72	22,053
12/7/2021	Gary Ingenito	Insider	Sell	3,612	$6.99	$25,247.88
8/25/2021	Philip H. Coelho	Director	Sell	9,498	$5.56	$52,808.88	233,427
8/25/2021	Steve Miller	COO	Sell	80,000	$5.56	$444,800.00	821,724
8/23/2021	Patrick J. McEnany	CEO	Sell	82,617	$5.62	$464,307.54	4,928,304
8/20/2021	Patrick J. McEnany	CEO	Sell	54,161	$5.52	$298,968.72
8/17/2021	Alicia Grande	CFO	Sell	100,000	$5.67	$567,000.00	507,441

Healthcare Takes A Big Step Forward With The Help Of AI

From The Bull Report | Ad

The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.

Click here to see why this small company is trusted by the Mayo Clinic

SEC Filings (Institutional Ownership Changes) for Catalyst Pharmaceuticals (NASDAQ:CPRX)

79.22% of Catalyst Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Catalyst Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/23/2024	Raymond James Financial Services Advisors Inc.	257,821	$4.11M	0.0%	-1.4%	0.218%
4/23/2024	Paradiem LLC	181,295	$2.89M	0.7%	-8.5%	0.154%
4/20/2024	Maryland State Retirement & Pension System	40,262	$0.64M	0.0%	+10.5%	0.034%
4/19/2024	State of Alaska Department of Revenue	68,038	$1.08M	0.0%	+10.4%	0.058%
4/19/2024	Sumitomo Mitsui Trust Holdings Inc.	26,700	$0.43M	0.0%	N/A	0.023%
4/18/2024	Allspring Global Investments Holdings LLC	143,481	$2.29M	0.0%	-7.6%	0.122%
4/16/2024	Toth Financial Advisory Corp	33,800	$0.54M	0.1%	+1,252.0%	0.029%
4/5/2024	Juncture Wealth Strategies LLC	94,583	$1.51M	0.6%	+764.0%	0.080%
4/5/2024	GAMMA Investing LLC	1,942	$31K	0.0%	+72.9%	0.002%
4/5/2024	Los Angeles Capital Management LLC	81,017	$1.29M	0.0%	+76.3%	0.069%
4/3/2024	Strategic Advocates LLC	13,278	$0.21M	0.1%	N/A	0.011%
3/22/2024	PNC Financial Services Group Inc.	12,960	$0.22M	0.0%	+15.3%	0.011%
3/12/2024	PVG Asset Management Corp	17,595	$0.30M	1.4%	N/A	0.015%
3/11/2024	Vanguard Group Inc.	7,120,417	$119.69M	0.0%	+1.0%	6.041%
2/23/2024	Cim LLC	27,163	$0.46M	0.1%	N/A	0.023%
2/15/2024	Opaleye Management Inc.	1,257,200	$21.44M	5.7%	+4.3%	1.069%
2/15/2024	Bridger Management LLC	184,527	$3.10M	1.2%	N/A	0.157%
2/13/2024	Tower Research Capital LLC TRC	6,184	$0.10M	0.0%	+84.5%	0.005%
2/13/2024	Rafferty Asset Management LLC	352,162	$5.92M	0.0%	-31.0%	0.300%
2/12/2024	Alberta Investment Management Corp	101,700	$1.71M	0.0%	+50.0%	0.087%
2/12/2024	Clark Estates Inc. NY	197,500	$3.32M	0.6%	+5.1%	0.168%
2/9/2024	JW Asset Management LLC	413,392	$6.95M	4.0%	-26.6%	0.352%
2/9/2024	US Bancorp DE	65,175	$1.10M	0.0%	+63.9%	0.055%
2/9/2024	Affinity Investment Advisors LLC	27,260	$0.46M	0.3%	-44.1%	0.023%
2/9/2024	Aigen Investment Management LP	43,517	$0.73M	0.1%	+144.8%	0.037%
2/9/2024	Franklin Resources Inc.	185,923	$3.13M	0.0%	+21.9%	0.158%
2/9/2024	Assetmark Inc.	64,678	$1.09M	0.0%	+4.0%	0.055%
2/9/2024	UBS Group AG	469,316	$7.89M	0.0%	+37.7%	0.399%
2/8/2024	Navellier & Associates Inc.	154,277	$2.59M	0.4%	+12.9%	0.131%
2/8/2024	Gables Capital Management Inc.	434,260	$7.30M	4.5%	+0.5%	0.369%
2/8/2024	Massachusetts Financial Services Co. MA	77,128	$1.30M	0.0%	-3.1%	0.066%
2/7/2024	Boston Partners	1,541,660	$25.61M	0.0%	+965.2%	1.311%
2/7/2024	Dimensional Fund Advisors LP	2,601,797	$43.74M	0.0%	+1.6%	2.213%
2/7/2024	Jump Financial LLC	64,122	$1.08M	0.0%	+100.5%	0.055%
2/7/2024	BNP Paribas Financial Markets	298,899	$5.02M	0.0%	+65.2%	0.254%
2/7/2024	Teacher Retirement System of Texas	22,438	$0.38M	0.0%	-21.8%	0.019%
2/7/2024	E Fund Management Co. Ltd.	18,913	$0.32M	0.0%	-27.9%	0.016%
2/6/2024	Charles Schwab Investment Management Inc.	956,333	$16.08M	0.0%	+3.8%	0.813%
2/6/2024	Gallacher Capital Management LLC	14,561	$0.25M	0.1%	-17.4%	0.012%
2/6/2024	LSV Asset Management	1,230,700	$20.69M	0.0%	-0.8%	1.047%
2/6/2024	Amalgamated Bank	43,449	$0.73M	0.0%	-2.0%	0.037%
2/6/2024	Summit Global Investments	90,512	$1.52M	0.1%	-7.1%	0.077%
2/6/2024	Westover Capital Advisors LLC	84,576	$1.42M	0.5%	-1.1%	0.072%
2/6/2024	Los Angeles Capital Management LLC	45,951	$0.77M	0.0%	-47.4%	0.039%
2/6/2024	Natixis Advisors L.P.	12,097	$0.20M	0.0%	N/A	0.010%
2/6/2024	Swiss National Bank	189,100	$3.18M	0.0%	-15.0%	0.161%
2/5/2024	Victory Capital Management Inc.	257,723	$4.33M	0.0%	-17.2%	0.219%
2/5/2024	Paradiem LLC	198,219	$3.33M	0.9%	+18.8%	0.169%
2/5/2024	Russell Investments Group Ltd.	191,881	$3.23M	0.0%	+5.5%	0.163%
2/1/2024	Yousif Capital Management LLC	53,649	$0.90M	0.0%	-5.6%	0.046%
2/1/2024	Linden Thomas Advisory Services LLC	11,077	$0.19M	0.0%	N/A	0.009%
2/1/2024	Parkside Financial Bank & Trust	1,863	$31K	0.0%	N/A	0.002%
2/1/2024	New York State Common Retirement Fund	69,004	$1.16M	0.0%	-4.4%	0.059%
2/1/2024	Handelsbanken Fonder AB	25,277	$0.43M	0.0%	-9.3%	0.021%
1/31/2024	Federated Hermes Inc.	129,164	$2.17M	0.0%	-24.5%	0.110%
1/30/2024	Cornercap Investment Counsel Inc.	13,387	$0.23M	0.0%	-84.6%	0.011%
1/30/2024	Strs Ohio	56,100	$0.94M	0.0%	-5.2%	0.048%
1/29/2024	Louisiana State Employees Retirement System	50,100	$0.84M	0.0%	N/A	0.043%
1/26/2024	Cerity Partners LLC	17,231	$0.29M	0.0%	+11.5%	0.015%
1/26/2024	Moody Aldrich Partners LLC	307,912	$5.18M	0.9%	+12.6%	0.262%
1/25/2024	Allspring Global Investments Holdings LLC	155,234	$2.61M	0.0%	-67.3%	0.132%
1/25/2024	Nisa Investment Advisors LLC	5,079	$85K	0.0%	+306.3%	0.004%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	57,174	$0.96M	0.0%	-2.9%	0.049%
1/24/2024	Arizona State Retirement System	26,816	$0.45M	0.0%	-6.9%	0.023%
1/19/2024	State of Alaska Department of Revenue	61,652	$1.04M	0.0%	-1.2%	0.052%
1/16/2024	Raymond James Financial Services Advisors Inc.	261,432	$4.40M	0.0%	+9.7%	0.222%
1/16/2024	Raymond James & Associates	50,279	$0.85M	0.0%	+4.2%	0.043%
1/9/2024	First Hawaiian Bank	26,540	$0.45M	0.0%	-14.9%	0.025%
12/18/2023	Vanguard Group Inc.	7,046,487	$82.37M	0.0%	+2.5%	6.610%
12/7/2023	Hudson Bay Capital Management LP	300,000	$3.51M	0.0%	+50.0%	0.281%
11/30/2023	American Century Companies Inc.	899,478	$10.52M	0.0%	+20.6%	0.844%
11/22/2023	Graham Capital Management L.P.	24,173	$0.28M	0.0%	N/A	0.023%
11/17/2023	Jacobs Levy Equity Management Inc.	1,307,225	$15.28M	0.1%	-1.1%	1.226%
11/15/2023	Kennedy Capital Management LLC	636,366	$7.44M	0.2%	+110.2%	0.597%
11/15/2023	Alps Advisors Inc.	78,710	$0.92M	0.0%	-21.0%	0.074%
11/15/2023	Advisors Asset Management Inc.	318,980	$3.73M	0.1%	-1.0%	0.299%
11/15/2023	Alberta Investment Management Corp	67,800	$0.79M	0.0%	-31.8%	0.064%
11/15/2023	Glenmede Trust Co. NA	48,378	$0.57M	0.0%	+71.0%	0.045%
11/15/2023	AQR Capital Management LLC	476,800	$5.57M	0.0%	-25.8%	0.447%
11/14/2023	Gotham Asset Management LLC	114,006	$1.33M	0.0%	+3.2%	0.107%
11/14/2023	Sherbrooke Park Advisers LLC	10,544	$0.12M	0.0%	N/A	0.010%
11/14/2023	Sawgrass Asset Management LLC	13,743	$0.16M	0.0%	-15.9%	0.013%
11/14/2023	Westover Capital Advisors LLC	85,518	$1M	0.4%	-16.9%	0.080%
11/14/2023	Profund Advisors LLC	89,459	$1.05M	0.1%	-32.6%	0.084%
11/13/2023	Clark Estates Inc. NY	188,000	$2.20M	0.4%	N/A	0.176%
11/13/2023	Gallacher Capital Management LLC	17,637	$0.21M	0.1%	N/A	0.017%
11/13/2023	Federated Hermes Inc.	171,008	$2M	0.0%	+80.5%	0.160%
11/13/2023	Healthcare of Ontario Pension Plan Trust Fund	60,500	$0.71M	0.0%	-12.9%	0.057%
11/13/2023	Brandywine Global Investment Management LLC	217,209	$2.54M	0.0%	+2.2%	0.204%
11/13/2023	CenterBook Partners LP	13,577	$0.16M	0.0%	+20.0%	0.013%
11/13/2023	Aigen Investment Management LP	17,780	$0.21M	0.0%	-14.9%	0.017%
11/13/2023	Invesco Ltd.	1,027,601	$12.01M	0.0%	-16.1%	0.964%
11/13/2023	Rafferty Asset Management LLC	510,435	$5.97M	0.0%	-28.6%	0.479%
11/13/2023	PNC Financial Services Group Inc.	11,241	$0.13M	0.0%	+42.5%	0.011%
11/13/2023	DekaBank Deutsche Girozentrale	20,000	$0.24M	0.0%	N/A	0.019%
11/13/2023	E Fund Management Co. Ltd.	26,220	$0.31M	0.0%	-31.8%	0.025%
11/9/2023	Rhumbline Advisers	292,186	$3.42M	0.0%	+1.6%	0.274%
11/9/2023	Navellier & Associates Inc.	136,614	$1.60M	0.3%	+8.9%	0.128%
11/9/2023	Deutsche Bank AG	106,257	$1.24M	0.0%	-88.9%	0.100%
11/9/2023	Citigroup Inc.	258,326	$3.02M	0.0%	-9.8%	0.242%

Data available starting January 2016

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was founded in 2002 and is based in Coral Gables, Florida.

Today's Range

Now: $15.10

$14.94

$15.35

50 Day Range

MA: $15.44

$13.18

$17.01

52 Week Range

Now: $15.10

$11.09

$17.76

Volume

1,015,570 shs

Average Volume

1,309,859 shs

Market Capitalization

$1.78 billion

P/E Ratio

24.75

Dividend Yield

N/A

Beta

0.89

Who are the company insiders with the largest holdings of Catalyst Pharmaceuticals?: Catalyst Pharmaceuticals' top insider shareholders include:
Patrick J Mcenany (CEO)
Steve Miller (COO)
Steve Miller (Insider)
Alicia Grande (CFO)
David S Tierney (Director)
Donald A Denkhaus (Director)
Philip H Coelho (Director)
Brian Elsbernd (Insider)
Gary Ingenito (Insider)
Preethi Sundaram (Insider)
Carmen Jeffrey Del (Insider)
Learn More about top insider investors at Catalyst Pharmaceuticals.
Who are the major institutional investors of Catalyst Pharmaceuticals?: Catalyst Pharmaceuticals' top institutional shareholders include:
Raymond James Financial Services Advisors Inc. — 0.22%
Paradiem LLC — 0.15%
Allspring Global Investments Holdings LLC — 0.12%
Juncture Wealth Strategies LLC — 0.08%
Los Angeles Capital Management LLC — 0.07%
State of Alaska Department of Revenue — 0.06%
Learn More about top institutional investors of Catalyst Pharmaceuticals stock.
Which major investors are selling Catalyst Pharmaceuticals stock?: During the last quarter, CPRX stock was sold by these institutional investors:
Paradiem LLC
Allspring Global Investments Holdings LLC
Raymond James Financial Services Advisors Inc.
Within the previous year, company insiders that have sold Catalyst Pharmaceuticals company stock include:
Patrick J Mcenany (CEO)
Steve Miller (COO)
Steve Miller (Insider)
Alicia Grande (CFO)
David S Tierney (Director)
Learn More investors selling Catalyst Pharmaceuticals stock.
Which major investors are buying Catalyst Pharmaceuticals stock?: In the last quarter, CPRX stock was acquired by institutional investors including:
Juncture Wealth Strategies LLC
Los Angeles Capital Management LLC
Toth Financial Advisory Corp
Sumitomo Mitsui Trust Holdings Inc.
Strategic Advocates LLC
State of Alaska Department of Revenue
Maryland State Retirement & Pension System
GAMMA Investing LLC